Purpose of review Although urethral stricture is not highly prevalent, it remains a persistent reconstructive challenge due to its risk of recurrence despite advances in surgery. In parallel, experimental and translational research has expanded rapidly, particularly in animal modelling, fibrosis biology, and tissue engineering. This review highlights recent and clinically relevant developments in experimental and translational models of urethral stricture disease, with emphasis on reproducibility, biological relevance, and translational potential. Recent findings Recent studies have refined experimental urethral stricture models by prioritizing standardization, reproducibility, and functional assessment. Human molecular profiling has improved understanding of fibrotic mechanisms and helped anchor experimental findings to clinical disease. Tissue engineering has shifted from passive structural replacement toward biologically active and adaptive biomaterials designed to modulate the regenerative microenvironment. While several approaches show promise in large animal models and early clinical studies, translation remains limited and heterogeneous. Summary Experimental and translational research has generated important insights into urethral stricture disease and introduced innovative regenerative strategies. However, increasing experimental sophistication has not yet translated into clear clinical benefit. Approaches that combine reproducibility, functional relevance, and surgical practicality are most likely to impact future clinical practice, while cautious interpretation of early translational and clinical data remains essential.
Madec et al. (Tue,) studied this question.